Medical Cable Assembly Requirements: ISO 13485, USP Class VI and Sterilization

A medical cable assembly needs requirements that match its role, patient contact, and operating environment. An internal equipment harness faces different demands than a reusable surgical handpiece cable. Before choosing a supplier, verify quality controls, material suitability, sterilization compatibility, cleanliness, and traceability.

Certificates alone won't establish whether a cable meets your device specifications. You also need evidence covering the actual materials, manufacturing processes, and finished assembly.

ISO 13485 vs. ISO 9001 for a Cable Supplier

ISO 9001 provides a general framework for consistent quality management across industries. It covers processes such as document control, corrective action, and customer requirements.

ISO 13485 focuses on medical devices and applicable regulatory requirements. It adds medical-specific expectations for documented controls, risk-based processes, production activities, and traceability where applicable. ISO 9001 certification alone doesn't demonstrate conformity with ISO 13485.

When assessing medical cable assembly manufacturers, look beyond the certificate logo. Request the current certificate and check:

• Scope: Does it cover the activities relevant to your cable build?
• Location: Does it include the manufacturing site handling your order?
• Validity: Is the certificate current and independently verifiable?
• Implementation: Can the supplier show relevant process controls and records?

Ask how the supplier manages subcontractors, nonconforming products, and changes to approved processes.

An ISO 13485 certificate covers a quality management system. It doesn't establish electrical safety, biocompatibility, or sterilization performance for your particular assembly. Define the evidence you need separately in your supplier agreement and product specifications.

USP Class VI and ISO 10993 Biocompatibility

Biocompatibility requirements start with the cable's intended use. Identify whether any component contacts the patient directly or indirectly, the contact type, and its duration.

An enclosed medical wire harness with no patient contact requires a different assessment than an external cable resting against skin.

What USP Class VI establishes

United States Pharmacopeia (USP) Class VI refers to a plastics classification associated with biological reactivity testing under USP General Chapter 88. Its test framework includes systemic injection, intracutaneous, and implantation evaluations under specified conditions.

A supporting report provides evidence about the tested material. It doesn't establish that every assembly using that material is suitable for every patient-contact application.

Request the report, material grade, formulation identification, and extraction conditions. Check whether pigments, additives, and processing match your intended cable. Confirm the applicable chapter edition and revision status when setting specifications; legacy Class VI wording shouldn't become an unchecked purchasing requirement.

How ISO 10993 differs

The ISO 10993 biological evaluation framework considers biological safety within a risk-management process. The evaluation depends on contact characteristics, materials, manufacturing, and available evidence.

Relevant endpoints can include cytotoxicity, sensitization, irritation, and other biological effects. A qualified assessment determines which evidence or additional testing is necessary.

Evaluate the device in its finished condition, accounting for processing and sterilization where applicable. Adhesives, printing inks, cleaning residues, and overmolding can change the assessment. We recommend documenting these inputs before approving materials, so purchasing substitutions don't undermine your biological evaluation.

Sterilization Compatibility by Jacket Material (Autoclave, EtO, Gamma)

Start by deciding whether your cable requires sterilization, disinfection, or cleaning only. Then specify the method, processing conditions, and expected lifetime exposures.

The available sterilization methods expose materials to different stresses. Steam introduces heat and moisture, ethylene oxide (EtO) introduces a chemical sterilant, and gamma irradiation exposes polymers to ionizing radiation.

Compare material candidates

Use this table for initial screening. Material families don't establish approval of a jacket or finished cable.

Silicone sterilization behavior varies with the product type. Don't transfer elastomer compatibility assumptions to silicone gels or adhesives.

For medical-grade TPU, EtO can offer a useful route for heat-sensitive constructions. Gamma exposure may cause discoloration, while steam can damage unsuitable grades. PTFE's heat resistance doesn't imply radiation resistance.

Validate the complete assembly

A compatible jacket can't protect an unsuitable connector insert, adhesive, or overmold interface. Moisture ingress, weakened bonds, and insulation changes may appear before visible jacket damage.

For reusable assemblies, validate the claimed reprocessing life using the intended cleaning and sterilization sequence. Define electrical and mechanical acceptance criteria before testing. Depending on the design, these may include continuity, insulation resistance, dielectric withstand, pull strength, and flex performance.

EtO processing also requires appropriate aeration and assessment of applicable residual limits. Gamma validation needs defined dose limits and consideration of aging. A single successful exposure doesn't establish lifetime compatibility.

Cleanroom Assembly for Medical Cables

Medical use doesn't automatically require cleanroom assembly. Your contamination risk assessment should establish whether controlled conditions are necessary and which production stages need them.

ISO 14644-1 classifies air cleanliness by airborne particle concentration. A cleanroom classification alone doesn't establish microbiological cleanliness, acceptable bioburden, or product sterility.

Where cleanroom production applies, ask your supplier to document:

• The required classification and supporting qualification records.
• Environmental monitoring, gowning, and personnel training.
• Component cleaning and material-transfer procedures.
• Controls for particles, residues, and relevant microbial contamination.
• Packaging that maintains specified cleanliness during storage and transport.

Identify where soldering, trimming, or other debris-generating operations occur. Confirm how the supplier protects cleaned parts before final assembly and packaging.

If you require a sterile product, establish responsibility for sterilization validation and sterile-barrier packaging separately. Clean assembly supports contamination control, but it doesn't replace those activities.

Traceability and Lot Control

Traceability helps you investigate defects, assess changes, and identify affected products. For medical device manufacturers, incomplete records can widen an investigation and delay decisions about product containment.

Define traceability depth according to device risk, applicable requirements, and your quality agreement. Individual serial numbers aren't automatically necessary for every cable; controlled lot identification may meet the specified need.

Your agreed records should connect finished assemblies to relevant information, including:

• Wire, jacket compound, connector, and contact lots.
• Adhesive and overmolding material batches, where applicable.
• Approved drawings, bills of materials, and process revisions.
• Production dates, inspections, test results, and release authorization.
• Approved deviations, rework, and outsourced processing records.

Ask the supplier to demonstrate a backward trace from a shipped assembly to its component lots. Then request a forward trace showing which shipments used one selected material batch.

Agree on record retention, retrieval expectations, and change-notification requirements before production. Changes to resin grades, production sites, or sterilization subcontractors may require review and additional validation. We recommend treating these controls as purchasing requirements from the first order.

At OurPCB, our team works with you to establish scope before you commit to production. Bring your drawings, bill of materials, patient-contact classification, reprocessing requirements, and intended sterilization method, and we'll identify the documentation, testing, and traceability your approval process needs. Discuss your project with our medical cable assembly team to get started.

Medical Cable Assembly Requirements FAQs

Does a medical cable need separate FDA approval?

There's no universal Food and Drug Administration (FDA) approval requirement for every cable component. Its regulatory treatment depends on whether it forms part of a device or qualifies separately as a device or accessory. Confirm the classification and submission strategy for its intended use.

What electrical information should an RFQ include?

Include the pinout, operating voltage, current, shielding, signal requirements, and mating connectors. Specify cable length, tolerances, bend radius, and environmental exposure. Identify any device-level safety requirements that affect cable design and testing.

Can prototype materials differ from production materials?

Yes, but document the differences and limit what prototype results establish. A substitute resin or connector may support fit checks without supporting biological or sterilization validation. Use representative materials and processes for qualification builds.

Who should own cable tooling and test fixtures?

Define ownership in the purchasing agreement. Address maintenance, calibration where applicable, storage, replacement costs, and transfer rights. Clear terms help protect supply continuity.

Back to Top: Medical Cable Assembly Requirements: ISO 13485, USP Class VI and Sterilization